本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

99.41
+3.523.67%
成交量:76.85万
成交额:7,666.35万
市值:66.34亿
市盈率:-32.01
高:102.13
开:95.46
低:95.46
收:95.89
52周最高:116.00
52周最低:45.91
股本:6,673.61万
流通股本:5,341.51万
量比:1.06
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-3.1057
每股收益(LYR):-4.3376
净资产收益率:-85.79%
总资产收益率:-26.74%
市净率:44.58
市盈率(LYR):-22.92

数据加载中...

2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/09/19

重要事件披露

Form 8-K - Current report
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities